Results

Total Results: 1,217 records

Showing results for "description".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0128_07-01-2009.pdf
    January 01, 2009 - Topic Description Nominator: Individual Nomination Summary: The nominator is interested
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0263_12-28-2007.pdf
    January 01, 2007 - Topic Description Nominator: Public payer Nomination Summary: The nominator is interested
  3. effectivehealthcare.ahrq.gov/sites/default/files/mental-illness-disparities_disposition-comments.pdf
    May 26, 2016 - Comment Response Peer Reviewer #1 Findings I also thought that more information was needed on the description … We rearranged the report structure to add a description of the findings to the beginning of the result … We have included a description of and a citation for the DECIDE study in the “Future Areas for Research … Peer Reviewer #2 Background The Background was thorough in its description of the clinical problem … Peer Reviewer #4 Methods “Systematic review” may not be the most appropriate description of this
  4. effectivehealthcare.ahrq.gov/sites/default/files/ch_3-user-guide-to-ocer_130129.pdf
    September 21, 2012 - in subgroups; availability of strong a priori biological and epidemiological evidence; detailed description … endpoints related to outcomes, prespecification of hypotheses relating to subgroup effects, and detailed description
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
    September 01, 2011 - However, a description of meta-analysis goes beyond this report. … The description of industry funding has been removed. … The description of industry funding has been removed. … However, there was an error in the description of second study that has been corrected. … However, the description of methotrexate has been expanded.
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-risk-drugs-protocol.pdf
    July 27, 2023 - Intervention RQs 1-4: Not applicable (description of harms associated with anticoagulant use in the … Description of Included Studies To efficiently describe eligible studies, the full text of each potentially … 8, we will create a table to record the source of each relevant toolkit along with a 1–2 sentence description … Question 8, we will create a table to record the source of each relevant toolkit along with a 1–2 sentence description
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-surgical-report-cards.pdf
    July 01, 2023 - practice or comparing report card types (or assessing data quality of a report card) • No clear descriptionDescription of Included Studies To efficiently describe eligible studies, the full text of each potentially … Review Question 8, we will list the name and source of each relevant toolkit along with a 1-2 sentence description … MHS = Making Healthcare Safer Literature Searches for Studies of Effectiveness Description of Included
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopausal-symptoms-protocol-final.pdf
    October 15, 2024 - progesterone or norethindrone acetate)).mp. 26677 26 Structure # Searches Results Description … or insert*)).ti,bt,ab,kf. 9482 27 Structure # Searches Results Description 26 Paroxetine … ti,bt,kf. 37578 29 Structure # Searches Results Description 56 ("use" adj3 (medication … or therap*)).ti,bt,ab,kf. 155871 30 Structure # Searches Results Description 59 ( … ti,bt,ab,kf. 652 31 Structure # Searches Results Description 63 (access* adj3 (service
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/lifecycle-assessment-disposition-comments.pdf
    November 20, 2024 - There doesn’t appear to be any description of the decades of LCA work on waste management. … This section is much too short and just appears to be a description of several studies with no description … This is not a comprehensive description of the results and does not give basic information about system … The sections were intentionally reordered and a description has been added to the section to introduce … Peer reviewer #1 Findings Page 13 line 47, the description of LCA and the terminology used here is wrong
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0647-13114.pdf
    June 21, 2013 - Topic Description Nominator(s): Health care professional association Nomination The nominator is
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_overview.pdf
    June 24, 2014 - Topic Description Key Questions: 1.
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0161_09-01-2009.pdf
    January 01, 2009 - Topic Description Nominator: Organization Nomination Summary: The nominator is interested
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0119_06-17-2009.pdf
    January 01, 2009 - Topic Description Nominator: Organization Nomination Summary: The nominator is interested
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0456_07-27-2011.pdf
    January 01, 2011 - Topic Description Nominator: Health care professional association Nomination Summary:
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0136_07-21-2009.pdf
    January 01, 2009 - Topic Description Nominator: Individual Nomination Summary: The nominator is interested
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0064_11-23-2008.pdf
    January 01, 2008 - Topic Description Nominators: 1 anonymous individual, 1 individual Nomination Summary:
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0288_03-10-2008.pdf
    January 01, 2008 - Topic Description Nominator: Public payer Nomination Summary: The nominator is interested
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-comments.pdf
    November 04, 2020 - We have expanded the description of the inclusion and exclusion criteria and explained how they have … Suggest keeping all approach/method description together. … However, the description of study participants in the figure suggests that other comorbidities are … However, "community" might warrant additional description. … The description of the table is also a little confusing - percentages of unreported data? Noted.
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/obsessive-compulsive-disorder-disposition-comments.pdf
    December 06, 2024 - However, most studies did not provide a detailed description of providers, precluding a more granular … description.
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/asd-medical-disposition.pdf
    May 26, 2017 - There is a short but concise description of ASD and the problems associated with the condition. … We did not set specific parameters for small, medium, or large; we acknowledge that our descriptionDescription of included studies well done; table 2 provides a good overview of types of studies included … TEP Reviewer #5 Results I am not sure from the description why N-acetylcysteine is not low SOE. … TEP Reviewer #5 Results I am not sure from the description why melatonin is not low SOE.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: